İmaj Plak Alanı İn-Stent esteno Abstract Aim: n this study we have used uantitative coronary angiography ( CA) and the mage program in order to investigate the in uence of pla ue area, as identified prior to stent implantation, on the development of stent restenosis. Material and Method: 5180 coronary angiography procedures were performed between March 2008 and uly 2011. f these, 227 presented with in-stent restenosis. A er application of the exclusion criteria, 164 intracoronary stents implanted in 121 patients were retrospectively investigated. These stents were divided into two groups depending upon the clinical status of the patient: (a) those who developed in-stent restenosis (n: 77, 47 ), and (b) those who failed to develop in-stent restenosis (n: 87, 53 ). Narrowing by 50 or more, as identified during coronary angiography performed at least six months a er the stent implantation, was considered as positive for development of in-stent restenosis. Pla ue area measurement in the patients was performed using uantitative coronary angiography ( CA) and the mage program. esults: Pla ue area measurement when performed uantitatively revealed no statistically significant di erence between the groups (p 0.05). owever, significant di erence in area was observed when mage was used (p 0.05). Statistically significant di erences were observed between groups in terms of history of hypertension and hyperlipidemia, use of statins, D values, and lesion type (p 0.05) the di erence in terms of presence of diabetes or smoking status (p 0.05) was not significant. There was a relationship among the development of restenosis and hypertension, non-usage of statin therapy, D level, poor lesion type, and pla ue area as measured with mage . Discussion: ypertension, non-usage statin therapy, low levels of D , poor lesion type, and larger pla ue areas as measured with the mage program were identified as important indicators for development of in-stent restenosis.
Introduction ntracoronary stenting has emerged as one of the most commonly used therapeutic modalities for the treatment of coronary artery disease. owever, one of the most serious problems encountered during the follow-up of patients who have received this treatment is the development of in-stent restenosis. t is di cult to determine the exact rate of restenosis because it depends on a number of di erent factors and variables. n the pre-stent era it ranged between 32-55 of all angioplasties, dropping to 17-41 1-4 in the BMS era 5-7 . A further step to reduce restenosis was undertaken with the advent of DES, with a reduction to numbers 10 8-9 . owever, in one study, within a time frame of six months nearly 20-35 of patients with bare-metal stents and 5-10 of those with drug-eluting stents developed this complication 10 . eports in the literature have pinpointed several factors suspected to be active in the development of restenosis 11-14 . These include advanced age, history of diabetes, long lesion, small vessel diameter, and poor lesion type. Some studies have suggested that monitoring the pla ue area prior to the last stent implantation could help in predicting restenosis via using intravascular ultrasound ( S) [15] [16] . As a result of this, interventions aimed at decreasing the pla ue material are popularly considered to reduce restenosis as well however, the expected results have not been obtained 17 . n this study we have used uantitative coronary angiography ( CA) and the mage program to investigate the in uence of pla ue area, as measured prior to stent implantation, on the development of restenosis. e have also monitored and analy ed several clinical, biochemical, and angiography-related factors.
Material and Method

Study Population
The study included patients who had undergone coronary angiography at the Cardiology Department Coronary Angiography nit between March 2008 and uly 2011. This inclusion was irrespective of the presence or absence of in-stent restenosis.
f the 5180 coronary angiography procedures, 227 presented with in-stent restenosis whereas 383 did not develop the same. Medical records and prior history of these patients, as present in the database, were analy ed retrospectively. nly those patients who had undergone the stent implantation procedure at our clinic were enrolled in the study. Patients whose stent implantation procedure was performed elsewhere, patients whose files could not be accessed, and patients who presented with stent thrombosis were excluded from the study group. n total, 164 intracoronary stents implanted in 121 patients were found to match the inclusion criteria and hence were investigated retrospectively as part of the analysis procedure. These stents were divided into two groups depending upon the clinical status of the patient: (a) those who presented with in-stent restenosis (n: 77, 47 ), and (b) those who failed to develop in-stent restenosis (n: 87, 53 ). Narrowing by 50 or more, as identified during coronary angiography performed at least six months a er the stent implantation, was considered as positive for development of in-stent restenosis. All characteristics of the patients that could potentially be related to the development of restenosis, including basic demographic characteristics such as age and gender, smoking status, hypertension, hyperlipidemia, diabetes, currently used drugs, and biochemical parameters, were meticulously recorded. Angiographic Examination and Evaluation of the Pla ue Burden ecords pertaining to the coronary angiography procedure performed during the stent implantation were obtained for each patient. The pla ue area present prior to the stent implantation was investigated semi-uantitatively using coronary angiography ( CA) and the mage program. The pla ue area was calculated semi-uantitatively using the Siemens Axiom (Germany) coronary angiography instrument.
ur analysis was based on the best possible view of the lesion-containing segment of the coronary artery into which the stent was implanted. sing the CA method, calibration was performed based on the catheter diameter and the segment with stenosis was marked on the coronary angiography instrument. The margins of the lesion were adjusted manually and the pla ue area was optimally calculated using the instrument ( Figure 1 ). Pla ue area calculations were done by two separate observers and the average of the results was used. Pla ue area calculation with both the methods was performed using the same image. An image of the pla ue area, as calculated by the CA method, was recorded in PEG format and the pla ue area was calculated using mage . The mage program is easily accessed via the internet (http:// rsbweb.nih.gov) and can be used to perform two-dimensional area calculation. Calibration is performed prior to area calculation. Then the area that needs be calculated is marked manually (Figure 2) . n this study, we accepted the catheter diameter as a reference value with which the calibration was performed. ACC/ A A lesion classification was used for coronary lesion type 18 . The reproducibility of two-dimensional area calculation was assessed by coe cients of variation (standard deviation of differences between the repeated measurements divided by the mean value and expressed as a percentage) between measurements. The intra-observer variability was calculated in 34 randomly selected study participants (18 patients who presented with in-stent restenosis and 16 control patients who did not develop in-stent restenosis) by repeating the measurements under the same basal conditions. ntra-observer and inter-observer variation was found to be 5 . 
Statistical analysis SPSS (Statistical
Results
A total of 164 stents were included as part of the study. f these, 77 were found to have developed in-stent restenosis whereas 87 failed to do so. No significant di erences were observed between the two groups with respect to age, gender, presence of diabetes mellitus, and smoking status (p 0.05).
owever, the prevalence of hypertension and hyperlipidemia was statistically significantly higher in patients with in-stent restenosis (p 0.05).
hen the current drug regimen was taken into account, a significant di erence in the development of in-stent restenosis was observed for the use of statins (p 0.05). t was observed that the risk for development of in-stent restenosis was lower in patients undergoing statin therapy as compared to those who were prescribed other medication. The development of in-stent restenosis was not found to be associated with the use of aspirin, clopidogrel, ticlopidine, or beta-blocker (p 0.05, Table 1 ).
hen basic laboratory parameters for all the patients were analy ed, no single factor was seen to make a statistically significant di erence between the two groups except for D , whose levels were lower in the patient group diagnosed with in-stent restenosis (p 0.05, Table 1 ). The patients with and without in-stent restenosis were investigated with respect to the type of percutaneous coronary intervention (PC ) associated with the stent implantation procedure.
f the 77 stents that were diagnosed with in-stent restenosis, 66 (85.7 ) were implanted using elective PC , nine (11.7 ) using primary PC , and two (2.6 ) with rescue PC . f the 87 Table  2 ). Amongst the 77 stents with in-stent restenosis, it was observed that 68 (88.3 ) were bare-metal stents (BMS) and nine (11.7 ) were drug-eluting stents (DES). f the 87 stents without instent restenosis, 67 (77.0 ) were BMS and 20 (23.0 ) were DES. hen the correlation between type of implanted stent and development of restenosis was evaluated, a statistically non-significant di erence was determined (p 0.091). owever, it can be stated that the use of drug-eluting stents was more fre uent in the group that failed to develop in stent restenosis ( Table 2 ). The performance of percutaneous transluminal coronary angioplasty (PTCA) prior to the stent implantation was also compared for the two groups. f the 77 stents that presented with in-stent restenosis, 38 (49.4 ) were observed to have undergone PTCA whereas 39 (50.6 ) did not due to decisions related to coronary by-pass operation and medical treatment. n the 87 stents that did not develop in-stent restenosis, 40 (46.0 ) were noted to have undergone PTCA because of thrombus burden of the lesion whereas 47 (54.0 ) did not. pon comparison, groups with and without in-stent restenosis did not demonstrate any statistically significant di erence with respect to the performance of the PTCA (p 0.05).
The two groups were compared with respect to the performance of post-dilatation a er stent implantation. f the 77 stents with in-stent restenosis, ten (13.0 ) underwent postdilatation and 67 (87.0 ) did not. f the 87 stents that did not develop in-stent restenosis, ten (11.5 ) underwent postdilatation and 77 (88.5 ) did not. Statistically there was no significant di erence between the two groups (p 0.05). The stents implanted in the two groups were compared in terms of stent si e and diameter. Statistically significant di erence was observed for di erence in stent si e (p 0.05) but not for stent diameter (p 0.05).
There was no statistically significant di erence between the two groups with respect to the uantitative pla ue area determined during follow-up coronary angiography (p 0.05) importantly, the pla ue area as examined with mage displayed no di erence between the groups (p 0.05).
There was a moderately positive correlation between the uantitative measurement of the pla ue area and the measurement of pla ue area done with mage (r 0.60, p 0.001).
Considering the aforementioned evaluations, the factors that were found to make a di erence between stents that did and did not develop restenosis included the presence of hypertension, presence of hyperlipidemia, non-usage statin therapy, lower D levels, longer stent si e, type of lesion, and pla ue area as calculated by mage . ogistic regression analysis was performed with factors associated with the risk for development of in-stent restenosis (Table 3) . Although a significant di erence was observed between the groups with and without in-stent restenosis in terms of hyperlipidemia and stent si e, logistic regression analysis revealed that these variables were not in uential for the development of in-stent restenosis (p 0.05).
Discussion
Detailed analysis performed during the course of our study revealed no significant di erence between patients with and without in-stent restenosis with respect to the pla ue area calculated through CA, whereas pla ue area as measured with mage was larger in those with restenosis. Correlation analysis revealed a significant correlation between CA and the pla ue area as measured through mage . egression analysis determined that the pla ue area measured with mage was a significant determinant for the development of in-stent restenosis. Every 1 mm2 increase in the pla ue area as measured with mage was found to cause a 1.11-fold increase in the development of restenosis. Although popularly used in the research arena, CA is unable to replace visual assessment in clinical practice because it is both time-consuming as well as technologically intensive. Another disadvantage is that finali ing the s uare and segment for which measurement will be performed is a subjective matter and hence is known to vary among people who perform this measurement using the CA method. Therefore, mage is a more practical and serviceable alternative method. ntracoronary stent implantation, an invasive revasculari ation method, has become the therapy of choice for coronary artery disease and its popularity is increasing on a daily basis. nfortunately, in spite of advancements in the materials used and an increase in the rate of procedural success, no concordant improvement in terms of in-stent restenosis, the main problem a ecting percutaneous coronary interventions, has yet been achieved. A meta-analysis of 11 studies that included a total of 5103 patients showed that the prevalence of angiographic in-stent restenosis was 5-10 in case of DES and 20-35 in case of BMS 10 . Some previously published studies have identified pre-procedural pla ue burden as a predictor of restenosis. Although the mechanism underlying the relationship between pla ue burden and restenosis are not clear, pla ue burden has emerged as a potential indicator. A high pre-procedural pla ue burden could hinder optimal dilatation of the stent. To overcome this problem, balloon angioplasty with higher pressure could be performed but doing so would increase the trauma e ect on the vascular walls which in turn would increase the risk of restenosis. Another study advanced the explanation that atherosclerotic pla ue burden could be the source for cells involved in the intimal hyperplasia process 15 . o man et al. investigated various predictors for development of restenosis following stent implantation and also tried to address the uestion of whether pla ue burden was in uential in the process. n their study they examined the pla ue burden before stent implantation using intravascular ultrasound ( S) and found that the pla ue burden was correlated with development of restenosis 15 . Similarly, a study by Shiran et al. showed that the preprocedural pla ue area as measured using S was a strong predictor for restenosis 16 . Considering that the real-life data show that S is not commonly used by interventional cardiologists, mage can be developed as a useful and convenient process to assess the pla ue burden. Subse uent comparative studies with S would give better information about the usefulness of this method. Previous studies have suggested that factors such as gender and age can function as predictors of in-stent restenosis development, but their impact still needs to be conclusively assessed. A study by Gupta et al. revealed that female gender is a risk factor for restenosis 19 . A study by Bainey et al. reached the same conclusion 20 . ther sources have defined gender and advanced age as predictors of restenosis 21 . n our study, no significant di erence could be uncovered between the two groups with respect to gender and age.
hen the two groups were compared, hypertension emerged as a clinical factor that was capable of in uencing the development of in-stent restenosis patients with hypertension were at a 4.5-fold greater risk for developing the complication. Similar to our study results, a report by Kastrati et al. also definitively identified hypertension as a risk factor for restenosis 22 . n our study, the prevalence of diabetes was 33.8 in the group with restenosis and 33.3 in the group without stenosis. There was no significant di erence between the groups and the presence of diabetes did not appear to increase the risk for in-stent restenosis. ur results are in direct contradiction to several previously published studies that have reported contrary results 23-26 . ne factor that can account for the lower incidence of restenosis in the diabetic pool of our study could be the more fre uent use of DES and the relatively limited number of patients.
Study Limitations
The number of enrolled patients and the study design were entirely based on the retrospective analysis of patient files therefore the database can be presented as a major limitation of our study. The data of the patients who underwent second coronary angiography in another clinic or who did not re uire coronary angiography were unavailable.
Conclusions
No correlation was observed between CA measured pla ue area and the development of restenosis. owever, a significant link was observed between pla ue area measured with mage and the development of restenosis. The presence of a correlation between the two methods indicates that the latter methodology can potentially prove useful in cardiology practice, furnishing clinicians with sensitive and significant findings. ntra-procedural techni ues aimed at reducing the pla ue burden could prove e ective for decreasing restenosis development but more extensive research on this subject needs to be conducted and better methodology needs to be developed for the purpose.
